Proteon Therapeutics (PRTO) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PRTO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineProtara Therapeutics Inc (TARA)investing.com - April 24 at 4:21 PMiPad Promacrumors.com - February 2 at 5:28 PMEsperion Therapeutics Inc ESPRmorningstar.com - November 5 at 4:53 AMThe Latest Analyst Ratings for Revance Therapeuticsbenzinga.com - September 20 at 8:42 AMENLV - Enlivex Therapeutics Ltd.finance.yahoo.com - June 7 at 12:06 AMPrelude Therapeutics Insider Trades Send a Signalbenzinga.com - May 25 at 3:00 PMGlobal Protein Therapeutics Market Report 2023: Development of Plasma Derived Therapies Drives Growthbenzinga.com - May 23 at 12:25 AMRAPT Therapeutics Announces FLX475 Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meetingbenzinga.com - April 26 at 6:30 PMEarly Adopter of Remote Therapeutic Monitoring Achieves Significant Clinical and Financial Outcomesbenzinga.com - February 22 at 10:26 AMCadrenal Therapeutics Announces Pricing of Initial Public Offering (IPO)finance.yahoo.com - January 22 at 6:13 PMAdvanced Proteome Therapeutics Announces Its Proposed Plan of Arrangementwsj.com - January 19 at 8:29 PMPeripheral Arterial Disease (PAD) Therapeutics Market 2023 Size & Segmentation Analysis with Share, Trends till 2028 [ NEW REPORT ]marketwatch.com - January 19 at 12:23 AMBusiness & Academia Join Forces To Study Magic Mushroom Therapy For IBS Patientsbenzinga.com - January 3 at 3:29 PMWhat 5 Analyst Ratings Have To Say About PTC Therapeuticsmsn.com - October 17 at 5:53 PMWhat 6 Analyst Ratings Have To Say About Revance Therapeuticsmsn.com - September 22 at 10:23 AMPropella Therapeutics Announces Presentation of Phase 1/2 Data of PRL-02 for the Treatment of Advanced Prostate Cancer at ESMO Congress 2022finance.yahoo.com - September 9 at 4:35 AMProthioneTM Capsules Reduced Time to COVID-19 Clinical Resolution and Decreased Viral Load in Phase II Clinical Trialfinance.yahoo.com - June 15 at 9:31 AMBristol-Myers To Buy Turning Point Therapeutics In $4.1 Billion Oncology Dealthestreet.com - June 3 at 10:41 PMFlagship Pioneering launches protein startup with $75Mbizjournals.com - May 27 at 6:28 AM Get Proteon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. PRTO Media Mentions By Week PRTO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTO News Sentiment▼0.000.32▲Average Medical News Sentiment PRTO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTO Articles This Week▼10▲PRTO Articles Average Week Get Proteon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Aligos Therapeutics News Genenta Science News Turnstone Biologics News Ikena Oncology News Entera Bio News Cidara Therapeutics News Instil Bio News Elutia News Semper Paratus Acquisition News Cognition Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTO) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteon Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
